[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"updates-archive-2026-09-21-14":3},{"date":4,"filings":5,"has_more":562,"limit":563,"page":564,"total_count":565},"2026-09-21",[6,14,21,25,32,39,46,50,57,61,68,72,80,84,91,98,105,109,115,122,126,133,137,144,148,155,158,163,167,174,181,185,192,196,203,207,214,218,225,229,236,240,247,251,258,265,270,274,281,285,290,294,299,303,310,317,321,326,333,337,344,348,355,362,366,373,377,384,388,395,400,404,411,415,422,426,433,437,444,448,453,457,461,468,472,479,483,489,496,500,507,511,518,522,529,536,540,547,551,558],{"company_name":7,"filing_date":8,"filing_source":9,"headline":10,"id":11,"stock_code":12,"summary_text":13},"Oxford Industries Ltd","2026-09-21T15:15:47.707000","BSE","Plans to Relocate Registered Office from Maharashtra to Odisha","6ab0fd04ce0745e6d905e677","514414","• The company proposes to shift its Registered Office from the State of Maharashtra to the State of Odisha.\n• This move was approved by shareholders via a special resolution at the 45th Annual General Meeting (AGM) held on September 11, 2026.\n• A public notice has been published in newspapers inviting objections to the proposed shift.\n• Any person affected can submit objections to the Regional Director (Western Region) within 14 days from the publication date of September 19, 2026.",{"company_name":15,"filing_date":16,"filing_source":9,"headline":17,"id":18,"stock_code":19,"summary_text":20},"Narmada Gelatines Ltd","2026-09-21T15:15:45.601000","Action Required: Update KYC to Receive Your Dividend","6ab0fcff6fdd865e29b45f0d","526739","• The dividend of ₹11.00 per share for FY 2025-26 has been withheld for 185 shareholders who are not KYC-compliant.\n• This action is due to SEBI regulations mandating all dividend payments be made electronically.\n• Affected shareholders must update their bank and contact details to receive their payment.\n• Physical shareholders need to submit forms (ISR-1, etc.) to the RTA, while Demat holders must update details with their Depository Participant.",{"company_name":15,"filing_date":16,"filing_source":9,"headline":22,"id":23,"stock_code":19,"summary_text":24},"Action Required: Update Your KYC to Receive Your Dividend!","6ab0fd1a9a7875c51e492a98","*   The company has withheld the final dividend of **₹11.00 per share** for the financial year 2025-26 for 185 shareholders.\n*   Payment is on hold because these shareholders are not **KYC-compliant**, and SEBI mandates all dividends be paid electronically.\n*   Affected shareholders have been notified and must update their PAN, bank account details, and other information to receive their payment.\n*   Shareholders with physical shares should contact the RTA (MUFG Intime India), while those with demat accounts should contact their Depository Participant.",{"company_name":26,"filing_date":27,"filing_source":9,"headline":28,"id":29,"stock_code":30,"summary_text":31},"Bajaj Global Ltd","2026-09-21T15:15:42.701000","Highlights from the 41st Annual General Meeting","6ab0fcf5d5d224e95cb45f21","512261","*   The company held its 41st Annual General Meeting (AGM) on September 21, 2026, to transact ordinary and special business.\n*   Members voted on the adoption of the Audited Financial Statements for the financial year ended March 31, 2026.\n*   Resolutions were passed for the appointment of three new directors (Mrs. Ruchita Jain, Mrs. Shweta Jejani, and Mr. Akshay Ranka) and the re-appointment of one director (Shri. Monal Malji).\n*   The consolidated results of the remote e-voting and ballot voting are pending and will be announced within two working days from the AGM.",{"company_name":33,"filing_date":34,"filing_source":9,"headline":35,"id":36,"stock_code":37,"summary_text":38},"Kiaasa Retail Ltd","2026-09-21T15:15:39.053000","Trading Window Closure Announced","6ab0fce3590907e7a6492a55","544711","*   The Trading Window for dealing in the company's securities will be closed for all designated persons and their immediate relatives.\n*   The closure is in anticipation of the declaration of financial results for the half-year ending September 30, 2026.\n*   The window will remain closed from **October 1, 2026**, until 48 hours after the financial results are announced.",{"company_name":40,"filing_date":41,"filing_source":9,"headline":42,"id":43,"stock_code":44,"summary_text":45},"Shri Vasuprada Plantations Ltd","2026-09-21T15:15:37.381000","Confirms Timely Interest Payment on Debentures","6ab0fce941537e3b3005e691","538092","*   The company has certified the timely payment of interest on its 9% Rated Listed Senior Secured Redeemable Non-Convertible Debentures (NCDs).\n*   Interest payment was successfully made on the due date, September 21, 2026.\n*   A gross interest amount of ₹1.04 crore was paid to the holders of NCDs with ISIN: INE574G07010.\n*   This filing confirms compliance with SEBI regulations and is a positive event for debenture holders, assuring them of the company's financial discipline.",{"company_name":40,"filing_date":41,"filing_source":9,"headline":47,"id":48,"stock_code":44,"summary_text":49},"Confirms Timely Interest Payment on Non-Convertible Debentures (NCDs)","6ab0fd0b8d76baaea2492a6b","*   The company has made a timely interest payment on its 9% Rated Listed Senior Secured Redeemable Non-Convertible Debentures (ISIN: INE574G07010).\n*   The interest payment, due on September 21, 2026, was successfully paid on the same day with no delay.\n*   A total interest amount of ₹1,04,35,069 was due and has been paid.\n*   This filing is a mandatory compliance update under SEBI Regulation 57, confirming the company's adherence to its debt servicing obligations.",{"company_name":51,"filing_date":52,"filing_source":9,"headline":53,"id":54,"stock_code":55,"summary_text":56},"SVC INDUSTRIES Ltd","2026-09-21T15:15:37.351000","Trading Window Closure Ahead of Q2 & H1 FY27 Results","6ab0fce58d76baaea2492a6a","524488","*   The company has announced the closure of its trading window in compliance with SEBI's Insider Trading regulations.\n*   The closure is in anticipation of the Board Meeting to approve the Unaudited Financial Results for the quarter and half-year ended September 30, 2026.\n*   The trading window will be closed from **Thursday, October 1, 2026**, until 48 hours after the financial results are declared.\n*   This restriction applies to all designated persons, insiders, directors, and their immediate relatives.\n*   The date of the Board Meeting for approving the results will be announced separately.",{"company_name":51,"filing_date":52,"filing_source":9,"headline":58,"id":59,"stock_code":55,"summary_text":60},"Trading Window to Close from Oct 1, 2026","6ab0fd0c590907e7a6492a56","*   The trading window for the company's equity shares will be closed for all \"Designated persons\u002FInsiders\u002FDirectors and their immediate relatives\".\n*   The closure is in preparation for the Board Meeting to approve the Unaudited Financial Results for the quarter and half-year ending September 30, 2026.\n*   The closure period will begin on Thursday, October 1, 2026.\n*   The trading window will reopen 48 hours after the financial results are declared to the Stock Exchange.\n*   The date of the Board Meeting for approving the results will be announced in due course.",{"company_name":62,"filing_date":63,"filing_source":9,"headline":64,"id":65,"stock_code":66,"summary_text":67},"One Global Service Provider Ltd","2026-09-21T15:15:36.600000","Updates Terms of Preferential Allotment for Acquisition","6ab0fd050f6e28b3f6224f10","514330","* The company has revised the terms of a special resolution for its upcoming AGM on Sep 29, 2026, following queries from the BSE.\n* The preferential allotment to acquire a 51% stake in Matrix Labs Diagnocare & Matrix Labs Private will now involve issuing **7,06,068 shares**, down from 7,15,040.\n* The issue price has been increased to **₹560.13** and **₹558.99** per share for the respective acquisitions, based on an updated valuation as per SEBI regulations.\n* The total consideration for the acquisition remains unchanged. The revision results in slightly lower equity dilution for existing shareholders.",{"company_name":62,"filing_date":63,"filing_source":9,"headline":69,"id":70,"stock_code":66,"summary_text":71},"Key Revisions to Preferential Issue for Acquisition","6ab0fd1be601f6640db45f55","*   The company has revised the terms of a proposed preferential share issue, which is part of a plan to acquire a 51% stake in Matrix Labs Diagnocare Pvt Ltd and Matrix Labs Pvt Ltd.\n*   The changes were made following guidance from the BSE on pricing regulations.\n*   \u003Cb>Key Revisions:\u003C\u002Fb> The total shares to be issued are now 7,06,068 (down from 7,15,040), with revised issue prices of ₹560.13 and ₹558.99 per share for the respective acquisitions.\n*   \u003Cb>Impact:\u003C\u002Fb> The promoter's shareholding will be diluted from 68.40% to 66.01% post-issue.\n*   Shareholders will vote on these revised terms at the upcoming AGM on September 29, 2026.",{"company_name":73,"filing_date":74,"filing_source":75,"headline":76,"id":77,"stock_code":78,"summary_text":79},"Vision Infra Equipment Solutions Limited","2026-09-21T15:15:27.900000","NSE","Highlights from the 3rd Annual General Meeting","6ab0fce0e601f6640db45f54","VIESL","*   The company conducted its 3rd Annual General Meeting (AGM) on September 21, 2026, to transact key business.\n*   Members voted on several resolutions, including the adoption of the FY26 financial statements, the re-appointment of Mr. Sameer Sanjay Gandhi as a Whole-time Director, and the approval of Material Related Party Transactions for FY 2026-27.\n*   Voting was conducted via e-voting and physical ballot. The final results are pending the Scrutinizer's Report and will be announced within two working days.",{"company_name":73,"filing_date":74,"filing_source":75,"headline":81,"id":82,"stock_code":78,"summary_text":83},"Summary of 3rd Annual General Meeting Proceedings","6ab0fd08ebb8aaa5fb224f22","*   The company has filed a summary of its 3rd Annual General Meeting (AGM) held on September 21, 2026.\n*   Shareholders voted on key resolutions, including the adoption of FY26 financial statements, the re-appointment of Mr. Sameer Sanjay Gandhi as a Whole-time Director, and the approval of material related party transactions.\n*   The results of the e-voting and ballot process are pending and will be declared within two working days from the conclusion of the AGM.",{"company_name":85,"filing_date":86,"filing_source":75,"headline":87,"id":88,"stock_code":89,"summary_text":90},"Onward Technologies Limited","2026-09-21T15:15:27.694000","Secures ₹44.46 Crore Contract Renewal with a 72% Increase in Value","6ab0fcddebb8aaa5fb224f21","ONWARDTEC","*   **Contract Renewal:** Renewed a multi-year Managed Digital Services contract with a leading global manufacturer of construction and mining equipment.\n*   **Total Contract Value:** ₹44.46 Crores.\n*   **Contract Tenure:** 3 years, from August 2026 to August 2029.\n*   **Significant Growth:** The new contract represents a 72% increase in value over the previous one, signaling strong client retention and growth.",{"company_name":92,"filing_date":93,"filing_source":75,"headline":94,"id":95,"stock_code":96,"summary_text":97},"Rollatainers Limited","2026-09-21T15:15:27.281000","Seeks Shareholder Approval for ₹100 Crore Acquisition","6ab0fced9a7875c51e492a97","ROLLT","• The Board of Directors has approved a proposal to acquire shares in **Satelite Forgings Private Limited** for a consideration not exceeding **₹100 Crores**.\n• The deal is classified as a **material Related Party Transaction (RPT)**, as the target company shares a common ultimate beneficial owner.\n• The company will seek shareholder approval for the acquisition via a **Special Resolution** at its 55th Annual General Meeting (AGM) on **September 30, 2026**.\n• The acquisition is intended to provide strategic\u002Feconomic benefits and create value for the company.",{"company_name":99,"filing_date":100,"filing_source":75,"headline":101,"id":102,"stock_code":103,"summary_text":104},"Neochem Bio Solutions Limited","2026-09-21T15:15:27.197000","Management to Participate in Upcoming Investor Conference","6ab0fcdbc14e4b3feb224f3d","NEOCHEM","• The company's management will participate in the 'Bharat Connect Conference – Rising Star 2026' organized by Arihant Capital.\n• The virtual conference is scheduled for Friday, September 25, 2026, at 2:00 PM.\n• Neochem has clarified that discussions will be based on publicly available information and no Unpublished Price Sensitive Information (UPSI) will be disclosed.",{"company_name":99,"filing_date":100,"filing_source":75,"headline":106,"id":107,"stock_code":103,"summary_text":108},"Management to Participate in Investor Conference","6ab0fcfd2edb40d8b305e6af","*   The company's management will participate in the \"Bharat Connect Conference\" organized by Arihant Capital.\n*   The virtual group meeting is scheduled for Friday, September 25, 2026, at 2:00 PM.\n*   Discussions will be based on generally available information, and the company has confirmed that no Unpublished Price Sensitive Information (UPSI) will be disclosed.",{"company_name":110,"filing_date":111,"filing_source":75,"headline":35,"id":112,"stock_code":113,"summary_text":114},"Dolphin Offshore Enterprises (India) Limited","2026-09-21T15:15:26.672000","6ab0fcd62edb40d8b305e6ae","DOLPHIN","*   The company has announced the closure of its trading window for designated persons and their immediate relatives.\n*   **Reason**: In preparation for the declaration of un-audited Financial Results for the quarter and half-year ending September 30, 2026.\n*   **Closure Period**: The window will be closed from October 1, 2026, and will remain closed until 48 hours after the financial results are declared (on or after November 16, 2026).\n*   **Compliance**: This action is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.",{"company_name":116,"filing_date":117,"filing_source":9,"headline":118,"id":119,"stock_code":120,"summary_text":121},"Infonative Solutions Ltd","2026-09-21T15:10:37.234000","Notice of Trading Window Closure","6ab0fbbfe601f6640db45f53","544393","• The company has announced the closure of its trading window in anticipation of its financial results for the half-year ending September 30, 2026.\n• The trading window will be closed from October 1, 2026, and will reopen 48 hours after the financial results are made public.\n• All designated persons, insiders, and their immediate relatives are prohibited from trading in the company's securities during this period.",{"company_name":116,"filing_date":117,"filing_source":9,"headline":123,"id":124,"stock_code":120,"summary_text":125},"Trading Window to Close from October 1, 2026","6ab0fbd641537e3b3005e690","• The trading window for dealing in the company's securities will be closed from October 1, 2026.\n• The closure will remain in effect until 48 hours after the financial results for the half-year ending September 30, 2026, are announced.\n• This restriction applies to all Designated Persons, their immediate relatives, and other company insiders.\n• The measure is a routine compliance step ahead of the announcement of financial results. The date of the announcement is yet to be declared.",{"company_name":127,"filing_date":128,"filing_source":9,"headline":129,"id":130,"stock_code":131,"summary_text":132},"Royal Sense Ltd","2026-09-21T15:10:37.210000","Conflicting Report on Promoter's Share Pledge","6ab0fbdec14e4b3feb224f3c","544143","*   Promoter Rishabh Arora filed a disclosure regarding the encumbrance (pledge) of his shares.\n*   The filing is officially labeled as a **\"RELEASE\"** of a pledge on 1,000,000 shares (18.69% of total capital).\n*   However, the data shows the number of pledged shares increased from **NIL to 1,000,000**, which is characteristic of a **\"CREATION\"** of a pledge, not a release.\n*   This significant contradiction creates uncertainty for investors, as the creation of a large pledge is a potential risk factor, while a release is generally positive.",{"company_name":127,"filing_date":128,"filing_source":9,"headline":134,"id":135,"stock_code":131,"summary_text":136},"Promoter Pledges 18.69% of Company Shares","6ab0fbde8d76baaea2492a69","*   Promoter Rishabh Arora has pledged 10,00,000 shares, representing 18.69% of the company's total share capital.\n*   The pledge was made to COMFORT SECURITIES LIMITED as security for financial assistance.\n*   This transaction increases the total promoter pledged holding from zero to 18.69% of the company.\n*   This action introduces a risk for shareholders, as a default could lead to the pledgee selling the shares in the open market, potentially causing a drop in the stock price.\n*   **Note:** The filing was marked as a \"RELEASE\" of pledge, but the data confirms it was a \"CREATION\" of a new pledge, indicating a likely clerical error.",{"company_name":138,"filing_date":139,"filing_source":75,"headline":140,"id":141,"stock_code":142,"summary_text":143},"Thyrocare Technologies Limited","2026-09-21T15:10:27.835000","Sells Subsidiary Nueclear Healthcare for ₹141.4 Crore to Focus on Core Business","6ab0fbc2ebb8aaa5fb224f20","THYROCARE","*   The company's board has approved the divestment of its 100% stake in the wholly-owned subsidiary, Nueclear Healthcare Limited (NHL), to Trovera Healthcare Private Limited.\n*   The total sale consideration is approximately ₹141.4 Crore, structured as ₹81.9 Crore in cash and ₹59.5 Crore in Compulsorily Convertible Preference Shares (CCPS) of Trovera.\n*   This strategic move is to exit the capital-intensive radiology business and sharpen the company's focus on its core pathology operations.\n*   As part of the deal, Thyrocare will acquire a ~4.5% stake in Trovera and purchase key lab properties in Gurugram and Hyderabad from NHL for ₹20.59 Crore to ensure operational continuity.\n*   The transaction is subject to shareholder approval and is expected to be completed by November 30, 2026.",{"company_name":138,"filing_date":139,"filing_source":75,"headline":145,"id":146,"stock_code":142,"summary_text":147},"Approves Sale of Radiology Subsidiary for ₹141.4 Crore","6ab0fbe8ce0745e6d905e676","*   The Board has approved the sale of its entire 100% stake in its wholly-owned subsidiary, Nueclear Healthcare Limited (NHL), to exit the radiology business.\n*   The total consideration is approximately **₹141.4 Crore**, payable by the buyer, Trovera Healthcare Private Limited.\n*   The payment consists of **~₹81.9 Crore in cash** and **~₹59.5 Crore in Compulsorily Convertible Preference Shares (CCPS)** of the buyer.\n*   This divestment will allow the company to focus its capital and management attention on its core pathology business.\n*   The transaction is subject to the approval of shareholders by way of a Special Resolution.",{"company_name":149,"filing_date":150,"filing_source":75,"headline":151,"id":152,"stock_code":153,"summary_text":154},"DCM Shriram International Limited","2026-09-21T15:10:27.488000","Intimation of Trading Window Closure","6ab0fbae41537e3b3005e68f","DCMSIL","*   The company has announced the closure of its Trading Window for all Designated Persons and their immediate relatives.\n*   This is in anticipation of the upcoming Board Meeting to approve the financial results for the quarter and half-year ending September 30, 2026.\n*   The Trading Window will remain closed from **Thursday, October 1, 2026,** until 48 hours after the financial results are declared.\n*   This action is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.",{"company_name":149,"filing_date":150,"filing_source":75,"headline":35,"id":156,"stock_code":153,"summary_text":157},"6ab0fbcc6fdd865e29b45f0c","*   The trading window for Designated Persons and their immediate relatives will be closed from **Thursday, October 01, 2026**.\n*   This closure is in anticipation of the declaration of Unaudited Financial Results for the quarter and half-year ending September 30, 2026.\n*   The window will reopen 48 hours after the financial results are made public.\n*   The date of the Board Meeting to approve the results will be announced in due course.",{"company_name":92,"filing_date":159,"filing_source":75,"headline":160,"id":161,"stock_code":96,"summary_text":162},"2026-09-21T15:10:27.101000","Board Approves ₹100 Crore Acquisition Proposal for Shareholder Vote","6ab0fbb79a7875c51e492a94","*   The Board of Directors has approved the proposed acquisition of **Satelite Forgings Private Limited** for a consideration not exceeding **₹100 Crores**.\n*   The transaction is classified as a **material Related Party Transaction** and requires shareholder approval.\n*   A **Special Resolution** for this acquisition will be voted on at the 55th Annual General Meeting (AGM) scheduled for September 30, 2026.\n*   The company cites \"strategic\u002Feconomic benefits\" and \"potential value creation\" as the rationale for the deal.\n*   Funding for the acquisition will be through an issue of securities, internal accruals, or available cash resources.",{"company_name":92,"filing_date":159,"filing_source":75,"headline":164,"id":165,"stock_code":96,"summary_text":166},"Proposes ₹100 Cr Acquisition of Related Party","6ab0fbdad5d224e95cb45f20","• The Board has approved a proposal to acquire shares in **Satelite Forgings Private Limited** for a consideration of up to **₹100 Crores**.\n• This is classified as a **material related party transaction** and requires shareholder approval.\n• The company will seek this approval via a **Special Resolution** at its 55th Annual General Meeting (AGM) on **30th September 2026**.\n• An addendum has been issued to the AGM notice to include this proposal as a new item of special business.\n• Management justifies the acquisition based on strategic benefits and potential value creation for the company.",{"company_name":168,"filing_date":169,"filing_source":75,"headline":170,"id":171,"stock_code":172,"summary_text":173},"Anlon Healthcare Limited","2026-09-21T15:10:26.864000","Expands into West Africa with New Nigerian Subsidiary","6ab0fbaec14e4b3feb224f3b","AHCL","• Incorporated a new subsidiary, **ANLON HEALTHCARE NIGERIA LIMITED**, to strategically expand its business in the West African market.\n• Anlon Healthcare will hold a **90% stake** in the new entity through an investment of **Naira 90,000,000** (Ninety Million Naira).\n• The Nigerian subsidiary will focus on manufacturing and trading pharmaceutical products, APIs, and medical devices.\n• This move is intended to provide access to 16 Western African countries and leverage growth in the African pharma segment.",{"company_name":175,"filing_date":176,"filing_source":75,"headline":177,"id":178,"stock_code":179,"summary_text":180},"HEC Infra Projects Limited","2026-09-21T15:10:26.529000","Secures New Domestic Order Worth ₹7.44 Crore","6ab0fbaf2edb40d8b305e6ad","HECPROJECT","*   The company has secured a new domestic order from Nakshatra Infra worth \u003Cb>₹7,44,60,921\u003C\u002Fb>.\n*   The project scope includes the supply, installation, testing, and commissioning of electrical, HVAC, and fire safety systems.\n*   The order is to be executed within a timeline of \u003Cb>6 months\u003C\u002Fb>.\n*   The company has confirmed this is \u003Cb>not a related party transaction\u003C\u002Fb>.",{"company_name":175,"filing_date":176,"filing_source":75,"headline":182,"id":183,"stock_code":179,"summary_text":184},"Secures New Order Worth ₹7.44 Crore","6ab0fbc90f6e28b3f6224f0f","*   \u003Cb>Order Value:\u003C\u002Fb> ₹ 7,44,60,921\n*   \u003Cb>Awarded by:\u003C\u002Fb> Nakshatra Infra (a Promoter Group Company)\n*   \u003Cb>Scope:\u003C\u002Fb> Supply, installation, testing, and commissioning of electrical, HVAC, and fire safety systems for a museum project in Vadodara.\n*   \u003Cb>Timeline:\u003C\u002Fb> To be executed within 6 months.",{"company_name":186,"filing_date":187,"filing_source":9,"headline":188,"id":189,"stock_code":190,"summary_text":191},"VSD Confin Ltd","2026-09-21T15:05:31.841000","Trading Window Closed Ahead of Quarterly Results","6ab0fa862edb40d8b305e6ac","531696","• The company has closed its trading window for designated persons in anticipation of its Unaudited Financial Results for the quarter ending September 30, 2026.\n• The closure is effective from September 21, 2026, with a specific restriction on trading from October 01, 2026.\n• The trading window will reopen 48 hours after the financial results are declared to the public.\n• The date of the Board Meeting to announce the results will be intimated at a later date.",{"company_name":186,"filing_date":187,"filing_source":9,"headline":193,"id":194,"stock_code":190,"summary_text":195},"Trading Window Closure for Quarter Ending Sep 2026","6ab0faa30f6e28b3f6224f0e","*   The company has announced the closure of its trading window in compliance with SEBI (Insider Trading) Regulations.\n*   The closure is for the purpose of declaring Unaudited Financial Results for the quarter ending September 30, 2026.\n*   The trading window will be closed from **October 01, 2026**, and will reopen 48 hours after the financial results are declared.\n*   This restriction applies to the company's Designated Persons, Designated Employees, and their Immediate Relatives.",{"company_name":197,"filing_date":198,"filing_source":75,"headline":199,"id":200,"stock_code":201,"summary_text":202},"Rossell India Limited","2026-09-21T15:05:27.548000","Clarifies Key Details on New Director Appointment","6ab0fa84e601f6640db45f52","ROSSELLIND","*   The company has provided a clarification to the National Stock Exchange (NSE) regarding the appointment of a Whole Time Director.\n*   The update confirms the appointment of **Mr. Digant Mahesh Parikh** as a Whole Time Director, effective from 26th August, 2026, for a term until 31st July, 2029.\n*   In response to the NSE's query, the company has explicitly stated that Mr. Parikh **has not been debarred** from holding the office of Director by SEBI or any other authority.",{"company_name":197,"filing_date":198,"filing_source":75,"headline":204,"id":205,"stock_code":201,"summary_text":206},"Clarifies Appointment of Whole Time Director","6ab0faa08d76baaea2492a68","• The company has clarified the appointment of **Mr. Digant Mahesh Parikh** as a **Whole Time Director**, effective August 26, 2026.\n• This filing is a response to a query from the National Stock Exchange (NSE) requesting complete details on the appointment.\n• Rossell India confirms that Mr. Parikh **has not been debarred** from holding the office of Director by SEBI or any other authority.\n• His term is for a period of about three years, until July 31, 2029.",{"company_name":208,"filing_date":209,"filing_source":75,"headline":210,"id":211,"stock_code":212,"summary_text":213},"Glenmark Pharmaceuticals Limited","2026-09-21T15:05:26.539000","Senior Management to Meet Investors","6ab0fa83c14e4b3feb224f38","GLENMARK","• The company has scheduled a meeting with institutional investors for September 29, 2026, in Mumbai.\n• The meeting will be attended by the company's Senior Management and hosted by PL Capital.\n• The agenda is a general \"Company Update and Investor Interaction\".\n• This filing is a mandatory notification and does not contain any new financial or operational data.",{"company_name":208,"filing_date":209,"filing_source":75,"headline":215,"id":216,"stock_code":212,"summary_text":217},"Upcoming Analyst & Investor Meet Scheduled","6ab0fa9cd5d224e95cb45f1f","*   The company has scheduled an in-person meeting with analysts and institutional investors, hosted by \"PL Capital - Emerging Titans\".\n*   The meeting will take place on September 29, 2026, at 09:00 AM in Mumbai.\n*   Senior Management will be present to represent the company and provide an update.",{"company_name":219,"filing_date":220,"filing_source":9,"headline":221,"id":222,"stock_code":223,"summary_text":224},"DHP India Ltd","2026-09-21T15:00:42.456000","AGM Highlights: Final Dividend of ₹4\u002Fshare Approved","6ab0f97ad5d224e95cb45f1e","531306","• A final dividend of **₹4 per share** (40%) for the financial year ended March 31, 2026, was approved by shareholders.\n• All three Ordinary Resolutions, including the adoption of financial statements and the dividend declaration, were passed with the requisite majority.\n• Mr. Janak Bhardwaj was re-appointed as a Non-Executive Director.\n• The update summarizes the proceedings of the 35th Annual General Meeting held on September 21, 2026.",{"company_name":219,"filing_date":220,"filing_source":9,"headline":226,"id":227,"stock_code":223,"summary_text":228},"AGM Update: Final Dividend of ₹4\u002Fshare Declared","6ab0f9859a7875c51e492a93","• Declared a final dividend of ₹4 per share (40%) for the financial year ended March 31, 2026.\n• All resolutions at the 35th Annual General Meeting (AGM), held on September 21, 2026, were passed with requisite majority.\n• Shareholders approved the re-appointment of Mr. Janak Bhardwaj as a Non-Executive Director.\n• The Audited Financial Statements for the year ended March 31, 2026, were adopted by the shareholders.",{"company_name":230,"filing_date":231,"filing_source":75,"headline":232,"id":233,"stock_code":234,"summary_text":235},"Taurian MPS Limited","2026-09-21T15:00:31.455000","Rectifies SDD Non-Compliance with NSE","6ab0f9688d76baaea2492a67","TAURIAN","• Addresses a non-compliance observation from the NSE regarding the maintenance of its Structural Digital Database (SDD).\n• Submitted compliance certificates for quarters ending Dec 2025, Mar 2026, and Jun 2026 to prove the issue is resolved.\n• The certificates affirm the company is now compliant with SEBI's Prohibition of Insider Trading (PIT) Regulations.\n• Requests the NSE to update its status to \"Compliant\" and clear the name of its Compliance Officer from the non-compliance dashboard.",{"company_name":230,"filing_date":231,"filing_source":75,"headline":237,"id":238,"stock_code":234,"summary_text":239},"Back in Compliance: Resolves SEBI Insider Trading Database Issue","6ab0f98de601f6640db45f51","*   The company has rectified a previously noted non-compliance with SEBI's Insider Trading regulations concerning the Structural Digital Database (SDD).\n*   Taurian MPS has submitted compliance certificates for the quarters ended Dec 2025, Mar 2026, and Jun 2026 to the National Stock Exchange (NSE).\n*   Compliance has been independently certified by a Practising Company Secretary, confirming the SDD is in place and meets all regulatory requirements.\n*   The company has formally requested the NSE to update its status to \"Compliant\" and remove the non-compliance flag from its records.",{"company_name":241,"filing_date":242,"filing_source":75,"headline":243,"id":244,"stock_code":245,"summary_text":246},"Simca Advertising Limited","2026-09-21T15:00:30.773000","Highlights from the 4th Annual General Meeting","6ab0f9610f6e28b3f6224f0d","SIMCA","*   The 4th Annual General Meeting (AGM) was successfully held on September 21, 2026.\n*   Members voted on key resolutions, including the adoption of the Standalone Financial Statements for the year ended March 31, 2026.\n*   A resolution for the re-appointment of Mr. Fahim Batliwala as a director was also put to vote.\n*   The consolidated voting results are pending the Scrutinizer's report and will be declared within 48 hours of the meeting's conclusion.",{"company_name":241,"filing_date":242,"filing_source":75,"headline":248,"id":249,"stock_code":245,"summary_text":250},"Key Updates from the 4th Annual General Meeting","6ab0f97aebb8aaa5fb224f1e","*   The 4th Annual General Meeting (AGM) was held on September 21, 2026, to discuss key company matters.\n*   Shareholders voted on several ordinary resolutions, including the adoption of the Standalone Financial Statements for the year ended March 31, 2026.\n*   Other key resolutions included the re-appointment of Mr. Fahim Batliwala as a director and the appointment of M\u002Fs SARK & Associates LLP as the Secretarial Auditor.\n*   The final results of the remote e-voting and votes cast during the AGM are pending the Scrutinizer's report and will be announced within 48 hours.",{"company_name":252,"filing_date":253,"filing_source":75,"headline":254,"id":255,"stock_code":256,"summary_text":257},"Jai Balaji Industries Limited","2026-09-21T15:00:29.982000","CRISIL Downgrades Credit Ratings","6ab0f950ebb8aaa5fb224f1d","JAIBALAJI","*   Credit rating agency CRISIL has downgraded the company's ratings for its bank loan facilities of ₹995 Crores.\n*   **Long-Term Rating:** Downgraded to **CRISIL BBB\u002FStable** from 'CRISIL BBB+\u002FStable'.\n*   **Short-Term Rating:** Downgraded to **Crisil A3+** from 'Crisil A2'.\n*   This action signals an increased perception of credit risk, which could potentially lead to higher borrowing costs for the company.",{"company_name":259,"filing_date":260,"filing_source":75,"headline":261,"id":262,"stock_code":263,"summary_text":264},"Piramal Finance Limited","2026-09-21T15:00:29.396000","Confirms Timely Interest Payment on NCDs","6ab0f959e601f6640db45f50","PIRAMALFIN","*   The company has certified the timely payment of interest on its Non-Convertible Debentures (NCDs) as of 21st September 2026, in compliance with SEBI regulations.\n*   This filing confirms the company is meeting its debt servicing obligations and is a positive signal for creditors and investors.\n*   Interest was paid on two NCDs (ISIN: INE641007144 and INE202B07JY0) with gross amounts of ₹217.84 Lakh and ₹404.27 Lakh, respectively.\n*   The document is a compliance filing and does not contain any new information on financial performance, strategy, or corporate actions.",{"company_name":138,"filing_date":266,"filing_source":75,"headline":267,"id":268,"stock_code":142,"summary_text":269},"2026-09-21T15:00:28.150000","Strategic Divestment of Radiology Arm for ₹141.4 Crore","6ab0f9742edb40d8b305e6ab","*   The Board has approved the sale of its entire 100% stake in its wholly-owned subsidiary, **Nueclear Healthcare Limited (NHL)**, to exit the radiology business.\n*   The total consideration for the sale is approximately **₹141.4 Crore**, with the buyer being Trovera Healthcare Private Limited.\n*   The payment is a mix of **₹81.9 Crore in cash** and **₹59.5 Crore in convertible preference shares** of the buyer, which will give Thyrocare an approximate 4.5% stake in Trovera.\n*   The strategic rationale is to sharpen focus and redeploy capital towards the **core pathology business**.\n*   As part of the deal, Thyrocare will also purchase key lab properties from NHL for ₹20.59 Crore to ensure operational continuity.\n*   The entire set of transactions is subject to shareholder approval and is expected to be completed by **November 30, 2026**.",{"company_name":138,"filing_date":266,"filing_source":75,"headline":271,"id":272,"stock_code":142,"summary_text":273},"Exits Radiology, Doubles Down on Pathology","6ab0f987ce0745e6d905e675","• \u003Cb>Strategic Divestment:\u003C\u002Fb> The Board has approved the sale of its entire 100% stake in its wholly-owned subsidiary, Nueclear Healthcare Limited (NHL), to Trovera Healthcare Private Limited.\n• \u003Cb>Deal Value:\u003C\u002Fb> Total consideration is approximately \u003Cb>₹141.4 Crore\u003C\u002Fb>, consisting of ~₹81.9 Crore in cash and a 4.5% stake in the buyer (Trovera) valued at ₹59.5 Crore.\n• \u003Cb>Strategic Rationale:\u003C\u002Fb> This move allows the company to exit the capital-intensive radiology business and focus its capital and management attention on its core pathology business.\n• \u003Cb>Property Purchase:\u003C\u002Fb> Concurrently, Thyrocare will purchase key real estate assets from NHL for ₹20.59 Crore to ensure continuity of its diagnostic lab operations in Gurugram and Hyderabad.\n• \u003Cb>Next Steps:\u003C\u002Fb> The entire transaction is subject to shareholder approval via a special resolution.",{"company_name":275,"filing_date":276,"filing_source":75,"headline":277,"id":278,"stock_code":279,"summary_text":280},"Transformers And Rectifiers (India) Limited","2026-09-21T15:00:28.049000","Highlights from the 32nd Annual General Meeting","6ab0f95e9a7875c51e492a92","TARIL","*   The 32nd Annual General Meeting (AGM) was held on September 21, 2026, to approve key resolutions.\n*   A dividend of 25% (i.e., \u003Cb>Rs. 0.25\u002F- per equity share\u003C\u002Fb>) was proposed for shareholder approval.\n*   Shareholders voted on the adoption of the audited standalone and \u003Cb>consolidated financial statements\u003C\u002Fb> for the financial year ended March 31, 2026.\n*   Other resolutions included the re-appointment of Mr. Satyen J. Mamtora as a director and the ratification of the Cost Auditor's remuneration.\n*   The final outcome of all resolutions is pending the declaration of the consolidated e-voting results, which will be announced within two working days.",{"company_name":275,"filing_date":276,"filing_source":75,"headline":282,"id":283,"stock_code":279,"summary_text":284},"Key Resolutions from 32nd AGM","6ab0f97541537e3b3005e68e","- The company has filed a summary of its 32nd Annual General Meeting (AGM) held on September 21, 2026.\n- A resolution was put to vote for the declaration of a dividend of 25% (₹0.25 per equity share).\n- The re-appointment of Mr. Satyen J. Mamtora as a Director was also proposed and put to vote.\n- Other resolutions included the adoption of financial statements for FY26 and the ratification of the Cost Auditor's remuneration.\n- The results of the voting on all resolutions are awaited and will be announced within two working days.",{"company_name":168,"filing_date":286,"filing_source":75,"headline":287,"id":288,"stock_code":172,"summary_text":289},"2026-09-21T15:00:27.954000","Anlon Healthcare Details Share Swap for Strategic Acquisitions","6ab0f966c14e4b3feb224f35","*   Anlon is acquiring significant stakes in \u003Cb>Apiqo Organics (44.94%)\u003C\u002Fb> and \u003Cb>Bizotic Lifescience (47.41%)\u003C\u002Fb> through a share swap.\n*   The company will issue new equity shares at a price of \u003Cb>₹17.85 per share\u003C\u002Fb> to facilitate the acquisitions.\n*   The plan was approved by shareholders at the AGM on September 5, 2026.\n*   This filing provides additional disclosures in response to queries from the BSE and NSE, ensuring transparency for shareholders.",{"company_name":168,"filing_date":286,"filing_source":75,"headline":291,"id":292,"stock_code":172,"summary_text":293},"Update on Proposed Share Swap and Preferential Issue","6ab0f97d590907e7a6492a54","- The company has provided additional disclosures regarding a proposed share swap, following observations from the BSE and NSE.\n- The purpose of the swap is to acquire a 44.94% stake in Apiqo Organics Private Limited and a 47.41% stake in Bizotic Lifescience Private Limited.\n- The final issue price for the new shares to be issued has been confirmed at **₹17.85 per share**, based on a revised valuation.\n- A revised list of the ultimate beneficial owners who will be allotted the shares has been disclosed for transparency.\n- The proposal was previously approved by shareholders at the Annual General Meeting held on September 5, 2026.",{"company_name":208,"filing_date":295,"filing_source":75,"headline":296,"id":297,"stock_code":212,"summary_text":298},"2026-09-21T14:55:30.806000","Investor Meeting Announcement","6ab0f836e601f6640db45f4f","• The company will participate in the PL Capital - Emerging Titans 2026 Conference.\n• The event is scheduled for September 29, 2026, in Mumbai.\n• Glenmark has confirmed that no unpublished price-sensitive information (UPSI) will be shared during the meeting.",{"company_name":208,"filing_date":295,"filing_source":75,"headline":300,"id":301,"stock_code":212,"summary_text":302},"Upcoming Investor & Analyst Meet","6ab0f84f6fdd865e29b45f0b","*   The company will attend the \"PL Capital - Emerging Titans 2026 Conference\" to meet with analysts and institutional investors.\n*   \u003Cb>Date:\u003C\u002Fb> September 29, 2026\n*   \u003Cb>Location:\u003C\u002Fb> Mumbai\n*   Glenmark has clarified that no unpublished price-sensitive information will be shared during the event.",{"company_name":304,"filing_date":305,"filing_source":75,"headline":306,"id":307,"stock_code":308,"summary_text":309},"Kuantum Papers Limited","2026-09-21T14:55:28.193000","Trading Window Closure for Q2 & H1 FY27 Results","6ab0f8322edb40d8b305e6aa","KUANTUM","*   The trading window for designated persons will be closed from **Thursday, October 1, 2026**.\n*   This is in anticipation of the unaudited financial results for the quarter and half-year ending September 30, 2026.\n*   The window will reopen 48 hours after the financial results are publicly declared.\n*   All Directors, KMPs, Designated Persons, and their relatives are prohibited from trading in the company's securities during this period.",{"company_name":311,"filing_date":312,"filing_source":75,"headline":313,"id":314,"stock_code":315,"summary_text":316},"Dilip Buildcon Limited","2026-09-21T14:55:28.190000","Sells Solar Portfolio Stake for ~₹6,829 Cr Enterprise Value","6ab0f8328d76baaea2492a66","DBL","\u003Cul>\u003Cli>Announced the divestment of its stake in a ~1,363 MW (AC) under-construction solar portfolio to Alpha Alternatives.\u003C\u002Fli>\u003Cli>The transaction is valued at an Enterprise Value of approximately \u003Cb>INR 6,829 Cr\u003C\u002Fb>.\u003C\u002Fli>\u003Cli>DBL will initially co-fund the project (51:49) and then sell its remaining 51% stake to Alpha Alternatives post-completion.\u003C\u002Fli>\u003Cli>This move is a key part of the company's \"DBL 2.0\" strategy to recycle capital, deleverage, and build an asset-light business model.\u003C\u002Fli>\u003C\u002Ful>",{"company_name":311,"filing_date":312,"filing_source":75,"headline":318,"id":319,"stock_code":315,"summary_text":320},"DBL to Divest Solar Portfolio for INR 6,829 Cr","6ab0f851590907e7a6492a53","*   Dilip Buildcon (DBL) has executed definitive agreements to divest its stake in its under-construction solar portfolio to Alpha Alternatives.\n*   The transaction is valued at an enterprise value of approximately **INR 6,829 Cr**.\n*   The portfolio consists of 1,363 MW of solar projects across 163 locations in Madhya Pradesh.\n*   The deal involves a two-phase structure: a 51:49 partnership for construction funding, followed by the sale of DBL's remaining 51% stake to Alpha Alternatives post-completion.\n*   This divestment is a key part of the company's \"DBL 2.0\" strategy to recycle capital, deleverage, and build an asset-light business.",{"company_name":304,"filing_date":322,"filing_source":75,"headline":323,"id":324,"stock_code":308,"summary_text":325},"2026-09-21T14:55:26.709000","Announces Trading Window Closure","6ab0f8219a7875c51e492a91","*   The trading window for designated persons will be closed from October 1, 2026.\n*   This closure is in anticipation of the declaration of financial results for the quarter and half-year ending September 30, 2026.\n*   The trading window will reopen 48 hours after the financial results are made public.\n*   This action is a standard compliance measure under SEBI's insider trading regulations to prevent trading by individuals with access to unpublished price-sensitive information.",{"company_name":327,"filing_date":328,"filing_source":75,"headline":329,"id":330,"stock_code":331,"summary_text":332},"Kaynes Technology India Limited","2026-09-21T14:50:32.970000","All Resolutions Passed at 18th Annual General Meeting","6ab0f7140f6e28b3f6224f0c","KAYNES","*   All 8 resolutions proposed at the 18th Annual General Meeting (AGM) held on September 17, 2026, were passed with the requisite majority, indicating strong shareholder support.\n*   Key governance updates include the re-appointment of four directors (including a Whole-Time Director and two Independent Directors) and the appointment of Messrs. Walker Chandiok & Co LLP as the new Statutory Auditors.\n*   A special resolution (No. 8) was passed, authorizing the company to grant loans, guarantees, and make investments.\n*   Notably, Resolution No. 8 passed with 86% of votes in favour, but faced significant opposition from Public Institutional shareholders, with 57.7% of their votes cast against it.",{"company_name":327,"filing_date":328,"filing_source":75,"headline":334,"id":335,"stock_code":331,"summary_text":336},"18th AGM Results: All Resolutions Approved by Shareholders","6ab0f7428d76baaea2492a65","*   All 8 resolutions proposed at the 18th Annual General Meeting (AGM) held on September 17, 2026, were passed with the requisite majority.\n*   Shareholders approved the appointment of Messrs. Walker Chandiok & Co LLP as the new statutory auditors.\n*   Key re-appointments were confirmed, including Mrs. Savitha Ramesh (Director), Mr. Jairam Paravastu Sampath (Whole-Time Director), and two Independent Directors.\n*   A special resolution was passed authorizing the company to grant loans, provide guarantees, and make investments under Section 186 of the Companies Act, 2013.",{"company_name":338,"filing_date":339,"filing_source":9,"headline":340,"id":341,"stock_code":342,"summary_text":343},"RR Financial Consultants Ltd","2026-09-21T14:50:30.330000","Key Proposals from 39th AGM","6ab0f70ce601f6640db45f42","511626","*   The 39th Annual General Meeting (AGM) was held on September 21, 2026, to consider several key resolutions.\n*   **Key Proposals:** Shareholders voted on a potential company name change, raising funds via non-convertible debentures (NCDs), and approving material related party transactions.\n*   **Director Re-appointment:** A resolution was proposed for the re-appointment of Ms. Priyanka Singh as a Director.\n*   **Next Steps:** The final voting results for all resolutions are pending and will be announced within 48 hours.",{"company_name":338,"filing_date":339,"filing_source":9,"headline":345,"id":346,"stock_code":342,"summary_text":347},"AGM Approves Name Change & Capital Raising Plans","6ab0f72b590907e7a6492a52","*   The 39th Annual General Meeting (AGM) was held on September 21, 2026, where several key resolutions were passed, pending final voting results.\n*   **Name Change:** Shareholders approved a special resolution to change the company's name.\n*   **Capital Raising:** Approval was granted to raise capital by issuing Non-Convertible Debentures through both public issue and private placement.\n*   **Director Re-appointment:** Ms. Priyanka Singh (DIN 05343056) was re-appointed as a Director.\n*   **Financials Adopted:** The Audited Financial Statements for the year ended March 31, 2026, were adopted.\n*   **Next Steps:** The final consolidated voting results from the scrutinizer will be submitted within 48 hours.",{"company_name":349,"filing_date":350,"filing_source":9,"headline":351,"id":352,"stock_code":353,"summary_text":354},"Libord Finance Ltd","2026-09-21T14:50:30.120000","Appoints New Company Secretary & Compliance Officer","6ab0f6fe590907e7a6492a51","511593","• Mr. Jay Rajeshkumar Modi has been appointed as the Company Secretary and Compliance Officer.\n• The appointment is effective from September 21, 2026.\n• Mr. Modi is an Associate Member of the Institute of Company Secretaries of India (ICSI) with experience in corporate laws.",{"company_name":356,"filing_date":357,"filing_source":9,"headline":358,"id":359,"stock_code":360,"summary_text":361},"Rikhav Securities Ltd","2026-09-21T14:50:30.049000","Investor & Analyst Meeting Scheduled","6ab0f70debb8aaa5fb224f1b","544340","*   A virtual group meeting with investors and analysts is scheduled for Thursday, September 24, 2026, at 4:00 PM IST.\n*   The company has confirmed that no Unpublished Price Sensitive Information (UPSI) will be discussed.\n*   Please note that the meeting schedule is subject to change or cancellation.",{"company_name":356,"filing_date":357,"filing_source":9,"headline":363,"id":364,"stock_code":360,"summary_text":365},"Investor & Analyst Meeting Scheduled for Sept 24","6ab0f71e2edb40d8b305e6a9","*   The company will hold a virtual meeting with investors and analysts on **Thursday, September 24, 2026, at 4:00 PM IST**.\n*   Rikhav Securities has confirmed that **no Unpublished Price Sensitive Information (UPSI)** will be discussed.\n*   The company noted that the meeting is subject to potential cancellation or rescheduling.",{"company_name":367,"filing_date":368,"filing_source":75,"headline":369,"id":370,"stock_code":371,"summary_text":372},"Jindal Saw Limited","2026-09-21T14:50:28.374000","CARE Ratings Reaffirms 'AA' & 'A1+' Credit Ratings","6ab0f711c14e4b3feb224f34","JINDALSAW","• CARE Ratings has reaffirmed the credit ratings for Jindal Saw's various banking facilities and debt instruments.\n• The long-term rating is maintained at \u003Cb>CARE AA\u003C\u002Fb> with a \u003Cb>\"Stable\"\u003C\u002Fb> outlook, indicating a high degree of safety regarding timely servicing of financial obligations.\n• The short-term rating is reaffirmed at \u003Cb>CARE A1+\u003C\u002Fb>, signifying a very strong capacity for meeting short-term commitments.\n• The rating action is based on the company's financial performance for FY26 (Audited) and Q1FY27 (Unaudited).\n• The ratings apply to total bank facilities of ₹11,123.79 crore and debt instruments worth ₹900.00 crore.",{"company_name":367,"filing_date":368,"filing_source":75,"headline":374,"id":375,"stock_code":371,"summary_text":376},"CARE Ratings Reaffirms 'AA; Stable' & 'A1+' Ratings","6ab0f72341537e3b3005e68d","*   CARE Ratings has reaffirmed the credit ratings for Jindal Saw's various bank facilities and debt instruments.\n*   **Long-Term Rating:** Maintained at 'CARE AA' with a 'Stable' outlook, indicating a high degree of safety.\n*   **Short-Term Rating:** Maintained at 'CARE A1+', indicating a very strong degree of safety.\n*   The ratings apply to total facilities and instruments worth ₹12,023.79 crore.\n*   This reaffirmation is a positive indicator for investors, reflecting the company's stable creditworthiness and timely servicing of financial obligations.",{"company_name":378,"filing_date":379,"filing_source":75,"headline":380,"id":381,"stock_code":382,"summary_text":383},"Ador Welding Limited","2026-09-21T14:50:27.466000","ESOP Update: 6,625 Options Vest & Plan Amended","6ab0f7058d76baaea2492a64","ADOR","*   The Nomination & Remuneration Committee has approved the vesting of **6,625 employee stock options** under the 'Ador Employee Stock Option Plan 2025'.\n*   The vesting date is **22nd September, 2026**, with an exercise price of **₹10 per share**.\n*   The ESOP plan has been amended to cap future grants at **2,000 options per employee** and to allot shares within 30 days of the exercise window closing.\n*   Additionally, **3,000 options** have lapsed due to employee resignations.",{"company_name":378,"filing_date":379,"filing_source":75,"headline":385,"id":386,"stock_code":382,"summary_text":387},"ESOP Update: 6,625 Options Vested for Employees","6ab0f7236fdd865e29b45f0a","*   The Nomination & Remuneration Committee has approved the vesting of 6,625 Employee Stock Options under the 'Ador Employee Stock Option Plan 2025'.\n*   The options will vest on 22nd September, 2026, at an exercise price of ₹10 per share.\n*   Eligible employees will have a 3-year period to exercise their vested options, starting from the vesting date.\n*   The company also amended its ESOP scheme, capping future grants at a maximum of 2,000 options per employee.\n*   The exercise of these options will result in the issuance of new equity shares, leading to a minor equity dilution.",{"company_name":389,"filing_date":390,"filing_source":75,"headline":391,"id":392,"stock_code":393,"summary_text":394},"FORCE MOTORS LTD","2026-09-21T14:50:26.908000","Board to Consider Removing Share Transfer Restrictions","6ab0f6f82edb40d8b305e6a8","FORCEMOT","*   The Board of Directors will hold a meeting on **September 25, 2026**.\n*   The key agenda is to consider and approve the removal of transfer restrictions on certain equity shares.\n*   The proposal affects 27,600 \"A\" Equity Shares and 1,15,748 \"Second A\" equity shares.\n*   If approved, these shares will become freely transferable, which would enhance their liquidity for the respective shareholders.",{"company_name":219,"filing_date":396,"filing_source":9,"headline":397,"id":398,"stock_code":223,"summary_text":399},"2026-09-21T14:45:32.479000","AGM Results: Final Dividend & Director Re-appointment Approved","6ab0f5f3e601f6640db45f41","• Shareholders approved a Final Dividend of \u003Cb>₹4 per equity share\u003C\u002Fb> for the financial year ended March 31, 2026.\n• Mr. Janak Bhardwaj was re-appointed as a Director of the company.\n• All resolutions proposed at the 35th Annual General Meeting (AGM) held on September 21, 2026, were passed with near-unanimous approval.",{"company_name":219,"filing_date":396,"filing_source":9,"headline":401,"id":402,"stock_code":223,"summary_text":403},"AGM Update: Final Dividend of ₹4\u002FShare Approved!","6ab0f5f4590907e7a6492a50","*   The company disclosed the voting results for its 35th Annual General Meeting (AGM) held on September 21, 2026.\n*   Shareholders approved a **Final Dividend of ₹4 per equity share** for the financial year 2025-26.\n*   The reappointment of **Mr. Janak Bhardwaj** as a Director was also approved.\n*   All resolutions, including the adoption of financial statements, were passed with a near-unanimous majority.",{"company_name":405,"filing_date":406,"filing_source":9,"headline":407,"id":408,"stock_code":409,"summary_text":410},"Resonance Specialties Ltd","2026-09-21T14:45:30.803000","Shareholders Approve ₹29.98 Cr Acquisition of Manufacturing Facility","6ab0f5edc14e4b3feb224f33","524218","*   Shareholders have approved the acquisition of a manufacturing facility from Kaygee Laboratories Private Limited for a consideration of **₹ 29.98 crores**.\n*   The transaction, identified as a **Material Related Party Transaction**, was approved via a postal ballot.\n*   The Ordinary Resolution was passed with **99.82%** of votes in favour.\n*   The acquisition of the Mandideep facility is on a slump sale basis and represents a significant capacity expansion for the company.",{"company_name":405,"filing_date":406,"filing_source":9,"headline":412,"id":413,"stock_code":409,"summary_text":414},"Gets Shareholder Nod for ₹29.98 Crore Acquisition of Manufacturing Facility","6ab0f5f76fdd865e29b45f09","*   The company has received shareholder approval to acquire the manufacturing facility of Kaygee Laboratories Private Limited (KLPL) located at Mandideep.\n*   The acquisition will be executed via a slump sale for a total consideration of **₹ 29.98 crores**.\n*   This was classified as a **Material Related Party Transaction**, requiring shareholder approval via a special resolution.\n*   The resolution was passed via a postal ballot with **99.82%** of votes cast in favour, indicating strong shareholder support for the expansion.",{"company_name":416,"filing_date":417,"filing_source":9,"headline":418,"id":419,"stock_code":420,"summary_text":421},"Gravity India Ltd","2026-09-21T14:45:30.276000","Posts Massive Turnaround, Plans ₹90 Cr Fundraise for Tech Expansion","6ab0f5f541537e3b3005e68c","532015","• **Financial Turnaround**: Swung from a net loss of ₹2.0 Cr (FY25) to a net profit of ₹12.8 Cr (FY26), driven by a massive 14,551% surge in turnover to ₹179 Cr.\n• **₹90 Cr Fundraise**: Proposes raising up to ₹90 Crore via a Qualified Institutions Placement (QIP) to fund working capital and growth, following a previously failed Rights Issue.\n• **Strategic Pivot**: Plans to diversify into new high-growth sectors, including Data Centres, Semiconductors, and AI, by altering its main business objectives (MOA).\n• **No Dividend**: The Board has not recommended a dividend for FY26 to conserve resources.\n• **Key AGM Proposals**: The 39th AGM (Sep 25, 2026) will vote on the QIP, MOA alteration, and the appointment of a new MD & CEO, CFO, and Statutory Auditor.",{"company_name":416,"filing_date":417,"filing_source":9,"headline":423,"id":424,"stock_code":420,"summary_text":425},"Announces Major Tech Pivot & ₹90 Crore Fundraise After Strong FY26 Results","6ab0f6118d76baaea2492a63","*   **Financial Turnaround:** Reported a massive turnaround for FY26, posting a net profit of ₹12.85 Crore against a loss of ₹2 Crore last year. Turnover surged over 14,500% to ₹179 Crore.\n*   **Strategic Pivot:** Plans a major strategic shift into high-growth tech sectors, seeking shareholder approval to enter the semiconductor, data centre, and AI industries.\n*   **Fundraising:** Proposes to raise up to **₹90 Crore** through a Qualified Institutions Placement (QIP) to fund the new ventures. This follows a failed Rights Issue in April 2026.\n*   **AGM & Correction:** The 39th AGM is on Sep 25, 2026. A correction has been issued: the remote e-voting period now ends on **Thursday, Sep 24, 2026**, at 5:00 PM.\n*   **No Dividend:** The Board has not recommended a dividend for the year in order to conserve resources for growth.",{"company_name":427,"filing_date":428,"filing_source":75,"headline":429,"id":430,"stock_code":431,"summary_text":432},"Emkay Global Financial Services Limited","2026-09-21T14:45:27.347000","Allots 1 Lakh Equity Shares to Promoter on Warrant Conversion","6ab0f5d72edb40d8b305e6a7","EMKAY","*   **Share Allotment:** The company has allotted 1,00,000 fully paid-up equity shares following the conversion of warrants.\n*   **Allottee:** The shares were allotted to Mr. Prakash Kacholia, a Promoter of the company.\n*   **Capital Infusion:** The company received Rs. 1.79 crore as the balance 75% consideration for this conversion, with the full issue price being Rs. 239.50 per share.\n*   **Impact on Capital:** The paid-up share capital has increased to Rs. 27.92 crore from Rs. 27.82 crore.\n*   **Promoter Holding:** As a result, Mr. Prakash Kacholia's shareholding in the company has increased from 19.41% to 19.70%.",{"company_name":427,"filing_date":428,"filing_source":75,"headline":434,"id":435,"stock_code":431,"summary_text":436},"Allots 1 Lakh Equity Shares on Warrant Conversion","6ab0f5f3ebb8aaa5fb224f1a","*   The company has allotted 1,00,000 equity shares to Promoter Mr. Prakash Kacholia upon the conversion of an equal number of warrants.\n*   The shares were allotted at an issue price of Rs. 239.50 per share, resulting in a cash inflow of Rs. 1.80 crore (approx.) for the company.\n*   Following the allotment, the company's paid-up share capital increased from Rs. 27.82 crore to Rs. 27.92 crore.\n*   Mr. Prakash Kacholia's shareholding in the company has increased from 19.41% to 19.70% as a result of this conversion.",{"company_name":438,"filing_date":439,"filing_source":75,"headline":440,"id":441,"stock_code":442,"summary_text":443},"Schneider Electric Infrastructure Limited","2026-09-21T14:45:26.938000","Schneider Electric Infrastructure Scores 70\u002F100 in Crisil ESG Rating","6ab0f5cf9a7875c51e492a90","SCHNEIDER","*   Received an ESG score of 70 out of 100 from Crisil ESG Ratings & Analytics, a SEBI-registered provider.\n*   The rating was unsolicited, prepared independently by the agency based on data in the public domain.\n*   The company is voluntarily disclosing the score to stock exchanges to promote transparency with investors and stakeholders.\n*   This disclosure was filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",{"company_name":438,"filing_date":439,"filing_source":75,"headline":445,"id":446,"stock_code":442,"summary_text":447},"Receives Strong ESG Score of 70\u002F100 from Crisil","6ab0f5e8d5d224e95cb45f1c","• The company has received an unsolicited ESG rating of 70 out of 100 from Crisil ESG Ratings & Analytics.\n• Crisil, a SEBI-registered provider, prepared the report independently based on public data.\n• Schneider Electric is voluntarily disclosing this rating to investors and stakeholders in line with good governance principles.",{"company_name":416,"filing_date":449,"filing_source":9,"headline":450,"id":451,"stock_code":420,"summary_text":452},"2026-09-21T14:40:36.190000","Auditors Issue Disclaimer of Opinion, Cite 'Going Concern' Risk","6ab0f4e46fdd865e29b45f08","*   **Extreme Red Flag**: The Statutory Auditor has issued a **Disclaimer of Opinion** on the FY 2025-26 financial statements, stating they could not obtain sufficient audit evidence. This means the reported financial results are not verifiable.\n*   **Going Concern Warning**: Auditors highlighted a **material uncertainty that may cast significant doubt on the Company's ability to continue as a going concern**.\n*   **Reported Performance**: Despite the warnings, the company reported a turnaround from a Net Loss of ₹200.58 Lacs (FY25) to a **Net Profit of ₹1,285.03 Lacs** (FY26).\n*   **Fundraising & Diversification**: The company seeks to raise **₹90 Crore via a QIP** and plans a major diversification into IT, data centers, and the semiconductor business.\n*   **Governance Lapses**: The Secretarial Audit Report noted numerous compliance failures, including improper regulatory filings and inaccurate record-keeping.",{"company_name":416,"filing_date":449,"filing_source":9,"headline":454,"id":455,"stock_code":420,"summary_text":456},"FY26 Profit Surge Met with Auditor's 'Disclaimer of Opinion' & Going Concern Warning","6ab0f508ebb8aaa5fb224f19","- **Financial Turnaround:** Reported a dramatic turnaround for FY26, with revenue surging to ₹179 Cr (from ₹1.2 Cr YoY) and a Net Profit of ₹12.8 Cr (from a ₹2 Cr loss).\n- **CRITICAL AUDIT RED FLAG:** The Statutory Auditor issued a **Disclaimer of Opinion** on the financial results, citing incomplete books, lack of supporting documents, and significant statutory non-compliances.\n- **GOING CONCERN WARNING:** The auditor also highlighted a **Material Uncertainty Related to Going Concern**, casting significant doubt on the company's ability to continue operations.\n- **Future Strategy & Fundraising:** The company is seeking shareholder approval to raise **₹90 Crore via a Qualified Institutions Placement (QIP)** and pivot into new sectors like IT, Data Centres, and Semiconductors.\n- **Recent Failed Fundraise:** A proposed Rights Issue in April 2026 failed to achieve the minimum required subscription, and the application money is being refunded.",{"company_name":416,"filing_date":449,"filing_source":9,"headline":458,"id":459,"stock_code":420,"summary_text":460},"Reports Profit Turnaround, But Auditors Issue Disclaimer of Opinion","6ab0f5302edb40d8b305e6a6","*   **Financial Turnaround:** The company reported a net profit of ₹1,285 Lacs for FY26, a significant turnaround from a loss of ₹200 Lacs in FY25, driven by a 14,551% surge in revenue from operations.\n*   **CRITICAL - Auditor's Disclaimer:** The Statutory Auditor has issued a **Disclaimer of Opinion** on the financial statements, stating they were unable to obtain sufficient audit evidence due to incomplete books, missing records, and statutory non-compliances.\n*   **CRITICAL - Going Concern Warning:** The auditor's report highlights a material uncertainty that may cast \"significant doubt on the company's ability to continue as a going concern.\"\n*   **Fundraising Plan:** The board is seeking approval to raise up to **₹90 Crore** via a Qualified Institutions Placement (QIP), following a failed Rights Issue earlier in the year.\n*   **Strategic Pivot:** Proposing to alter its main objectives to diversify into high-growth sectors like IT services, Data Centres, and Semiconductors.",{"company_name":462,"filing_date":463,"filing_source":9,"headline":464,"id":465,"stock_code":466,"summary_text":467},"Smart Finsec Ltd","2026-09-21T14:40:34.222000","Highlights from 31st Annual General Meeting","6ab0f4b10f6e28b3f6224f0b","539494","• The 31st Annual General Meeting (AGM) was held on September 21, 2026.\n• Members voted on the re-appointment of Ms. Vimmi Sachdev as a director.\n• Special resolutions were proposed to increase the company's borrowing limits and to approve the creation of charges on company assets.\n• An ordinary resolution was put to vote to adopt the Audited Financial Statements for the year ended March 31, 2026.\n• The results of the e-voting on all resolutions are pending and will be disclosed separately.",{"company_name":462,"filing_date":463,"filing_source":9,"headline":469,"id":470,"stock_code":466,"summary_text":471},"Highlights from the 31st Annual General Meeting","6ab0f4dfc14e4b3feb224f32","*   The 31st AGM was held on September 21, 2026, with 73 members attending via video conference.\n*   Shareholders voted on adopting the Audited Standalone Financial Statement for the year ended March 31, 2026.\n*   A resolution was proposed for the re-appointment of Ms. Vimmi Sachdev as a director.\n*   Special resolutions were put to vote to increase the company's borrowing limits and to approve the creation of a charge\u002Fsecurity on its assets.\n*   The results of the e-voting on these resolutions will be disclosed separately.",{"company_name":473,"filing_date":474,"filing_source":9,"headline":475,"id":476,"stock_code":477,"summary_text":478},"Tamilnadu Steel Tubes Ltd","2026-09-21T14:40:33.479000","Independent Director Completes Tenure, Departs Board","6ab0f4acebb8aaa5fb224f18","513540","*   Mrs. Divya Abishek (DIN: 08709050) has ceased to be an Independent Director upon the completion of her second and final tenure.\n*   The cessation is effective from the close of business hours on **September 20, 2026**.\n*   The Board of Directors acknowledged the completion of her term and passed a resolution expressing its \"sincere appreciation and gratitude\" for her contributions.\n*   This departure marks a key change in the Board's composition for shareholders to note.",{"company_name":473,"filing_date":474,"filing_source":9,"headline":480,"id":481,"stock_code":477,"summary_text":482},"Independent Director Completes Tenure","6ab0f4cc9a7875c51e492a8f","*   Mrs. Divya Abishek (DIN: 08709050) has ceased to be an Independent Director effective from the close of business hours on September 20, 2026.\n*   The change is due to the successful completion of her second and final tenure with the company.\n*   The Board of Directors passed a resolution expressing its sincere appreciation and gratitude for her invaluable contributions and services.",{"company_name":484,"filing_date":485,"filing_source":9,"headline":35,"id":486,"stock_code":487,"summary_text":488},"Envair Electrodyne Ltd","2026-09-21T14:40:33.403000","6ab0f4a7ce0745e6d905e673","500246","*   The trading window for the company's securities will be closed from **Thursday, October 1, 2026**.\n*   This is in anticipation of the Board Meeting to approve the financial results for the quarter ending September 30, 2026.\n*   The window will reopen **48 hours after** the financial results are declared to the stock exchange.\n*   This closure applies to Designated Persons and their immediate relatives as per insider trading regulations.",{"company_name":490,"filing_date":491,"filing_source":9,"headline":492,"id":493,"stock_code":494,"summary_text":495},"Continental Chemicals Ltd","2026-09-21T14:40:32.602000","Trading Window Closure Ahead of Q2 Results","6ab0f4b341537e3b3005e68b","506935","*   The trading window for designated persons will be closed from October 1, 2026.\n*   This is in compliance with SEBI regulations ahead of the announcement of financial results for the quarter and half-year ending September 30, 2026.\n*   The trading window will reopen 48 hours after the financial results are made public.\n*   The date of the Board Meeting to approve the results will be announced in due course.",{"company_name":490,"filing_date":491,"filing_source":9,"headline":497,"id":498,"stock_code":494,"summary_text":499},"Trading Window Closed Ahead of Q2\u002FH1 Results","6ab0f4d1e601f6640db45f40","*   The trading window will be closed for designated persons (insiders) and their dependents starting from **October 1, 2026**.\n*   This is in preparation for the announcement of financial results for the quarter and half-year ending **September 30, 2026**.\n*   The window will reopen 48 hours after the financial results are made public.\n*   This action is in compliance with SEBI's insider trading regulations to prevent trading on unpublished price-sensitive information.",{"company_name":501,"filing_date":502,"filing_source":75,"headline":503,"id":504,"stock_code":505,"summary_text":506},"Maruti Suzuki India Limited","2026-09-21T14:40:29.086000","Schedule of Investor Meeting","6ab0f4b2d5d224e95cb45f1b","MARUTI","• A meeting with an investor group is scheduled for 24th September 2026.\n• This is a regulatory intimation to the stock exchanges under SEBI (LODR) Regulations, 2015.\n• The company notes that the meeting date is subject to change.\n• No material financial information is disclosed in this filing.",{"company_name":501,"filing_date":502,"filing_source":75,"headline":508,"id":509,"stock_code":505,"summary_text":510},"Upcoming Investor Meeting Scheduled","6ab0f4cace0745e6d905e674","*   A meeting with an investor group is scheduled for September 24, 2026.\n*   This is a routine regulatory filing under SEBI (LODR) Regulations, 2015.\n*   The filing does not contain any new material financial or operational information.\n*   The company notes the meeting date is subject to change.",{"company_name":512,"filing_date":513,"filing_source":75,"headline":514,"id":515,"stock_code":516,"summary_text":517},"SPML Infra Limited","2026-09-21T14:40:27.843000","Announces Analyst & Investor Meet","6ab0f4aac14e4b3feb224f31","SPMLINFRA","*   The company's management will participate in a virtual meeting with investors and analysts on September 29, 2026.\n*   The meeting is with Arihant Capital as part of the \"Bharat Group Connect Conference Rising Star 2026\".\n*   SPML Infra has confirmed that no Unpublished Price Sensitive Information (UPSI) will be discussed during the meet.",{"company_name":512,"filing_date":513,"filing_source":75,"headline":519,"id":520,"stock_code":516,"summary_text":521},"Investor & Analyst Meet Announcement","6ab0f4c72edb40d8b305e6a5","• The management will participate in a virtual investor and analyst meet on 29th September 2026.\n• The meeting is part of the 'Arihant Capital - Bharat Connect Conference Rising Star 2026' and is scheduled from 01:00 PM to 02:00 PM.\n• The company has confirmed that no unpublished price-sensitive information (UPSI) will be discussed during the interaction.",{"company_name":523,"filing_date":524,"filing_source":75,"headline":525,"id":526,"stock_code":527,"summary_text":528},"Indian Oil Corporation Limited","2026-09-21T14:40:27.623000","Confirms Timely Redemption of Commercial Paper","6ab0f4a32edb40d8b305e6a4","IOC","*   The company has successfully redeemed and fulfilled payment obligations for a series of Commercial Paper (CP) that matured on September 21, 2026.\n*   This action pertains to 24,000 units of CP identified by the ISIN: INE242A14YY3.\n*   The successful and timely redemption demonstrates the company's financial discipline and ability to meet its short-term debt obligations.",{"company_name":530,"filing_date":531,"filing_source":75,"headline":532,"id":533,"stock_code":534,"summary_text":535},"Radha Madhav Corporation Limited","2026-09-21T14:40:27.248000","Clarifies Position on Consolidated Financial Reporting","6ab0f4a8e601f6640db45f3f","532692","\u003Cul>\n    \u003Cli>The company has clarified that the requirement to submit consolidated financial results is currently not applicable to it.\u003C\u002Fli>\n    \u003Cli>This is because the proposed acquisition of \u003Cb>Phytoatomy Private Limited\u003C\u002Fb> has not yet been completed.\u003C\u002Fli>\n    \u003Cli>Without a subsidiary, there is no basis for consolidation under Regulation 33 of the SEBI (LODR) Regulations.\u003C\u002Fli>\n    \u003Cli>RMCL has requested the stock exchange to take this clarification on record to avoid repeated queries on the matter.\u003C\u002Fli>\n\u003C\u002Ful>",{"company_name":530,"filing_date":531,"filing_source":75,"headline":537,"id":538,"stock_code":534,"summary_text":539},"Clarifies Stance on Consolidated Financials","6ab0f4bc8d76baaea2492a62","*   The company has filed a clarification stating it is not required to submit consolidated financial results at this time.\n*   This is because the proposed acquisition of a majority stake in **Phytoatomy Private Limited** is still in process and has not been completed.\n*   Since Phytoatomy is not yet a subsidiary, the SEBI regulation requiring consolidation (Regulation 33) does not apply to RMCL.\n*   Investors will continue to receive only standalone financial results until the acquisition is finalized.",{"company_name":541,"filing_date":542,"filing_source":75,"headline":543,"id":544,"stock_code":545,"summary_text":546},"Repco Home Finance Limited","2026-09-21T14:40:26.981000","Redeems ₹75 Crore in Commercial Papers","6ab0f4a89a7875c51e492a8e","REPCOHOME","*   The company has completed the full and timely redemption of its unlisted Commercial Papers (CPs) valued at ₹75 crores.\n*   The redemption occurred on the maturity date, 21st September, 2026.\n*   All holders of the CPs (ISIN: INE612J14596) have been duly paid.\n*   This action confirms the company's financial discipline and ability to meet its short-term debt obligations.",{"company_name":541,"filing_date":542,"filing_source":75,"headline":548,"id":549,"stock_code":545,"summary_text":550},"Successfully Redeems ₹75 Crore Commercial Papers","6ab0f4c0590907e7a6492a4f","*   The company has redeemed its unlisted Commercial Papers (CPs) valued at ₹75 crores upon maturity.\n*   The redemption and full payment to holders were completed on the due date, September 21, 2026.\n*   This action demonstrates the company's strong liquidity and financial discipline in meeting its short-term debt obligations.",{"company_name":552,"filing_date":553,"filing_source":75,"headline":554,"id":555,"stock_code":556,"summary_text":557},"Rajshree Polypack Limited","2026-09-21T14:35:34.215000","Clarifies Identical Standalone & Consolidated Financials","6ab0f3968d76baaea2492a61","RPPL","*   The company has responded to a query from the National Stock Exchange (NSE) regarding why its Standalone and Consolidated financial results for the quarter ended June 30, 2026, were identical.\n*   The reason is the accounting treatment of its Joint Venture (JV), Olive Ecopak Private Limited, as per accounting standard Ind AS 28.\n*   The company's investment in the JV was reduced to Nil in a prior period due to accumulated losses. Consequently, no further share of the JV's losses is being recognized in the consolidated statement, making it identical to the standalone one.\n*   Rajshree Polypack confirmed this treatment is compliant, reviewed by auditors, and that the same clarification has been provided to the exchange for previous quarters.",{"company_name":552,"filing_date":553,"filing_source":75,"headline":559,"id":560,"stock_code":556,"summary_text":561},"Explains Identical Standalone & Consolidated Results to Exchange","6ab0f3a541537e3b3005e68a","*   The company responded to a query from the National Stock Exchange (NSE) regarding why its Standalone and Consolidated financial results for the quarter ended June 30, 2026, were identical.\n*   This is due to the accounting treatment of its Joint Venture (JV), Olive Ecopak Private Limited, as per Ind AS 28.\n*   The company's investment in the JV was written down to Nil in a prior financial year (FY 2024-25) due to accumulated losses.\n*   As the investment value is Nil, the company has stopped recognizing any further share of losses from the JV.\n*   Since the JV's results were the only point of difference, the Standalone and Consolidated figures are now the same.\n*   The company noted it has provided the same clarification for similar queries in previous quarters.",true,100,14,1841]